Survival after antireflux surgery versus medication in patients with reflux oesophagitis or Barrett's oesophagus: multinational cohort study.
M YanesG SantoniJ Maret-OudaE Ness-JensenM FärkkiläE LyngeE PukkalaP RomundstadL TryggvadóttirM von Euler -ChelpinJesper LagergrenPublished in: The British journal of surgery (2021)
In patients with reflux oesophagitis or Barrett's oesophagus, antireflux surgery is associated with lower mortality from all causes, cardiovascular disease, respiratory disease, laryngeal or pharyngeal cancer, and lung cancer, but not from oesophageal cancer, compared with antireflux medication.
Keyphrases
- papillary thyroid
- cardiovascular disease
- minimally invasive
- coronary artery bypass
- squamous cell
- healthcare
- gastroesophageal reflux disease
- type diabetes
- adverse drug
- emergency department
- squamous cell carcinoma
- childhood cancer
- acute coronary syndrome
- metabolic syndrome
- risk factors
- cardiovascular risk factors
- drug induced